The Role of Gut Leakage Markers and Microbiota Signature in Coronary Artery Disease.
NCT ID: NCT04605627
Last Updated: 2020-10-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2020-10-08
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic coronary syndrome
50 patients with chronic coronary disease
No interventions assigned to this group
Non ST segment-elevation myocardial infarction
75 patients with non ST-elevation myocardial infarction
No interventions assigned to this group
ST-elevation myocardial infarction
75 patients with ST segment-elevation myocardial infarction
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Inflammatory bowel disease
* Renal failure with creatinine \> 200µmol/L
* Hepatic impairment
* Pregnancy
* Previous bariatric surgery
* Colostomy
* Active malignant disease
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Research Council of Norway
OTHER
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Geir Øystein Andersen
MD, PhD, Senior Cardiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marius Trøseid, Md Ass.prof
Role: PRINCIPAL_INVESTIGATOR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Cardiology, Oslo University Hospital Ullevål
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Oslo University Hospital
Identifier Type: -
Identifier Source: org_study_id